Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value for the Primary Completion date has been updated from an estimated date of 2026-04 to 2026-05. This change indicates a potential extension in the timeline for the completion of the study related to the long-term safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease.
    Difference
    0.2%
    Check dated 2024-06-06T14:18:45.000Z thumbnail image
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 02 01 02 has been updated to 31 in the webpage, indicating a change in the locations of clinical trial sites from Hialeah, Florida, United States, 33012 to West Palm Beach, Florida, United States, 33407, as well as the addition of new clinical trial sites in Czechia and Slovakia.
    Difference
    4%
    Check dated 2024-06-01T11:05:39.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that subjects must have completed study KAR-031 or KAR-032 and were aged 55 to 90 years at the time of enrollment in those studies. It also outlines the need for informed consent and the conditions under which subjects can continue participation if they relocate to a nursing home facility.
    Difference
    23%
    Check dated 2024-05-22T20:57:58.000Z thumbnail image
  8. Check
    38 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated completion date for the Phase 3 study assessing the long-term safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease.
    Difference
    0.1%
    Check dated 2024-05-04T09:39:33.000Z thumbnail image
  9. Check
    39 days ago
    Change Detected
    Summary
    The value 04 01 03 29 04 01 03 has been updated to 05 02 Miami, Florida, United States, 33174 Clinical Trial Site (Estimated) 05 02 05. This change likely indicates a new clinical trial site location in Miami, Florida, for a medical study related to psychosis associated with Alzheimer's Disease.
    Difference
    2%
    Check dated 2024-05-03T04:52:05.000Z thumbnail image
  10. Check
    42 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:14:45.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.